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Background: Incomplete P2Y12-inhibition during clopidogrel treatment is
associated with increased cardiovascular events and mortality after coronary
intervention.
The aim of this study was to evaluate the effect of high-dose clopidogrel
continuation treatment on the development of MACCE in patients with Cyto-
chrome P450 2C19*2 Loss-of-Function Allele.
Methods: Between May 2009, and september 2010, 100 patients who
underwent a percutaneous coronary intervention (PCI) and were exposed to
clopidogrel treatment for at least one month, were enrolled in our study. They
underwent CYP2C19*2 determination. The primary endpoint was a composite
of death, myocardial infarction, and urgent coronary revascularisation occur-
ring during exposure to clopidogrel.
Results: The use of a double maintenance dose of clopidogrel (150 mg)
was noted in 27% of cases, similarly in both study groups (28.6% in the non-
mutated versus 21.7 % in the mutant group (p=0.5).
This attitude was especially observed in diabetic patients, if drug-eluting
stent is used and in case of complex angioplasty (77% of patients on double
dose of clopidogrel are diabetics and 70% were implanted with a drug-eluting
stent).
The use of a double dose of clopidogrel results in a non significant
decrease in the occurrence of MACE in the non mutated group (10.9% vs 0%,
p=0.17) and has no effect in the mutated group (22% in a double dose of clop-
idogrel versus 20% p=0, 91).
Conclusion: Our study showed no relationship between the use of a double
dose of clopidogrel and reduced occurrence of MACE, irrespective of the
genetic profile studied.
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Objective: To investigate the determinants and the prognostic capacity of
fragmented QRS on a 12-lead ECG in patients with acute myocardial infarc-
tion.
Patients and methods: Prospective cohort of 307 consecutive patients
with AMI. Main outcomes measure: in-hospital adverse outcomes, thirty-day
and one year mortality. 
Results: 163 (53%) were found without fQRS (No fQRS group). 144
(47%) presented a fQRS on the first 36 hours 12-lead ECG, which was per-
sistent in 107 patients (persistent fQRS group) and non persistent in 37
patients (non-persistent fQRS group). Despite similar demographic features,
clinical presentation and reperfusion strategies, patients with a fragmented
QRS (transient or persistent) were older, more likely hypertensive and less
smoker were found among these groups. If in-hospital adverse outcomes were
similar between groups, interestingly we found a trend towards a greater like-
lihood of ventricular arrhythmias in the group without a fragmented QRS
when compared with other groups (12% vs. 5% vs. 4%, respectively,
p=0.054). An all-cause death at 30 days was similar in the three populations.
At one year’s follow-up, 45 (14.6%) patients had died from all causes and 30
(9.7%) from cardiovascular cause. The Kaplan Meier analysis revealed that
mortality was significantly higher in the fQRS group (persistent or not) than
in the non-fQRS group (30 (20%) vs. 15(9.2%) respectively, p=0.007). By
multivariate logistic regression analysis, age (p=0.008) and the presence of a
family history of CAD (p=0.043) were independent predictors of fQRS occur-
rence. In multivariate analysis six variables were significant predictors of all-
cause death at one year: age, DBP, glucose on admission, LVEF, treatment
with beta-blockers at the acute phase and presence of a fQRS.
Conclusions: The fQRS is an independent predictor of 1 year all cause
death after AMI, even after correction with age and LVEF, and It is associated
with lower event-free survival.
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Aims: Clopidogrel discontinuation after percutaneous coronary interven-
tion (PCI) with drug-eluting stent (DES) implantation has been reported to
correlate with stent thrombosis. Whether these events are a consequence of the
rebound phenomenon or a lack of protection in unhealed vessels is unclear.
This study aimed to determine the link between clopidogrel cessation and car-
diovascular events after PCI with DES. Methods and results: The population
included 1,903 patients who underwent PCI with DES implantation from 2003
to 2007. We compared patients who stopped their clopidogrel within the first
month (group 1, n=97), from one to six months (group 2, n=344), from six to
12 months (group 3, n=468), and after 12 months (group 4, n=994) following
the PCI. In each group, the composite of death, myocardial infarction and
stent thrombosis at 30 days and between 31 and 60 days after clopidogrel ces-
sation was indexed. Baseline characteristics were similar among groups. The
event rate observed in the 0-30 day interval following cessation was higher
only in group 1 (5.2%) compared to all other groups: 1.2% (group 2), 0.9%
(group 3) and 0.6% (group 4) (p=0.004). The event rates from 31 to 60 days
following cessation were low and similar among the four groups. When the
elapsed time between the index PCI and the clopidogrel cessation was anal-
ysed as a continuous variable, the probability of events occurring within the
first 30 days became similar to that observed in the 31-60 day interval fol-
lowing cessation after a minimum of 10.2 months. 
Conclusions: Cardiac events seen immediately after clopidogrel cessation
are not related to a rebound phenomenon, but are more likely influenced by
the lack of healing at the time of cessation, which decreases over time. This
increased risk related to the lack of healing seems to disappear after
10.2 months.
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Background: Coronary artery bypass surgery is recognised as the “gold
standard” treatment for unprotected left main (LM) stenosis. However,
advances in percutaneous coronary intervention techniques and the introduc-
tion of drug eluting stents have led to the acceptance of PCI as an alternative
strategy for complex lesions including LM lesions.
Methods: We performed a matched comparison of patients in the French
Left Main Taxus registry and the Left Main Xience registry undergoing
unprotected LM stenting with Taxus paclitaxel-eluting (PES) and Xience siro-
limus-eluting (SES) stents respectively, in 4 French centres. 172 patients were
matched according to Syntax score, stenosis involving the distal LM, provi-
sional side-branch T-stenting and use of one stent in the distal LM. 
Results: Patients were aged 69.5±11.3 years, 76.5 % of patients were
male. 25.3% of patients were diabetics and 27.3% had undergone previous
PCI. Mean Syntax score was 25.5±9.6. The distal LM was involved in 82%
and provisional SB T-stenting was performed in 91.1%.
The one- year follow-up results are shown in Table 1.
Patients were stratified according to the 3 SYNTAX score subgroups.
Patients with low SYNTAX score had similar outcomes for MACE at 1 year
(9.6% vs. 6.8%, p=0.67) for PES and EES respectively. Intermediate and high
